Search

Your search keyword '"Patent Code of 1952 (35 U.S.C. 101)"' showing total 171 results

Search Constraints

Start Over You searched for: Descriptor "Patent Code of 1952 (35 U.S.C. 101)" Remove constraint Descriptor: "Patent Code of 1952 (35 U.S.C. 101)"
171 results on '"Patent Code of 1952 (35 U.S.C. 101)"'

Search Results

1. Make It Make Sense: How Congress Can (and Should) Clarify Patent-Eligible Subject Matter.

2. Reinventing the 'Inventive Concept': Applying Copyright's Merger Doctrine to Patent Eligibility.

3. Beef, It's What's for Dinner in the Patent Office: A Call for Resolving Selective Breeding as Invention.

4. GENE PATENTS, DRUG PRICES, AND SCIENTIFIC RESEARCH: UNEXPECTED EFFECTS OF RECENTLY PROPOSED PATENT ELIGIBILITY LEGISLATION.

5. Rulemaking s. 101.

6. PATENT-ELIGIBILITY STANDARD FOR NETWORK ARCHITECTURE PATENTS UNDER THE FEDERAL CIRCUIT'S JURISPRUDENCE.

7. SCALPELS OVER SLEDGEHAMMERS: SAVING DIAGNOSTIC PATENTS THROUGH JUDICIAL INTERVENTION RATHER THAN LEGISLATIVE OVERRIDE.

8. DON'T ABSTRACT MACHINE LEARNING PATENTS.

9. PATENT ORIGINALISM.

10. Patents, Property, and Prospectivity.

11. THE PROMISING VIRAL THREAT TO BACTERIAL RESISTANCE: THE UNCERTAIN PATENTABILITY OF PHAGE THERAPEUTICS AND THE NECESSITY OF ALTERNATIVE INCENTIVES.

12. WAS DIEHR A FLOOK IN THE SYSTEM? A SYSTEMS ANALYSIS FOR TWO LANDMARK PATENT ELIGIBILITY SUPREME COURT DECISIONS.

13. Patentable subject matter: An American Axle update.

14. Patenting and protecting personalized medicine innovation post-Mayo, Myriad, and Limelight.

15. Out of Wonderland from Diehr to Aatrix: Three Steps to Overcoming 101 Rejections.

16. Responding to s. 101 Rejections.

17. Welcome to the Aatrix: Facts, Lots of Facts, Available for Eligibility Analyses?

18. Responding to s. 101 Rejections.

19. Are the Federal Circuit's Recent Section 101 Decisions a 'Specific Improvement' in Patent Eligibility Law?

20. How Are Diagnostic Methods Handled by the USPTO?

21. Are the Federal Circuit's Recent Section 101 Decisions a 'Specific Improvement' in Patent Eligibility Law?

22. How Are Diagnostic Methods Handled by the USPTO?

23. The patentability of digital 'manufactures' as 3D printing expands into the 4D world.

24. Patent 'trolls' and claim construction.

25. Patenting natural products after Myriad.

26. A quantitative approach to determining patentable subject matter.

27. A crisis of patent law and medical innovation: the category of diagnostic claims in the wake of Arioso v. Sequenom.

28. ALICE IN WONDERLAND: ARE PATENT TROLLS MORTALLY WOUNDED BY SECTION 101 UNCERTAINTY?

29. All that is solid melts into air: the subject-matter eligibility inquiry in the age of cloud computing.

30. Two models of unpatentable subject matter.

31. All that is solid melts into air: the subject-matter eligibility inquiry in the age of cloud computing.

32. Two models of unpatentable subject matter.

33. Applying patent-eligible subject matter restrictions.

34. The curious incident of the Supreme Court in Myriad Genetics.

35. Who will finance drug development if natural products are no longer patentable?

36. Software, abstractness, and soft physicality requirements.

37. Cyberspace-related patents since Alice.

38. Copyright's hand abstractions test for patent's section 101 subject-matter eligibility.

39. Copyright's hand abstractions test for patent's section 101 subject-matter eligibility.

40. How to explain the 'implicit exceptions' to patent-eligible subject matter.

41. Gene-patenting and access to healthcare: achieving precision.

42. Section 101 metrics: post-Alice district court rulings on section 101 motions.

43. Federal Circuit decision in Ariosa v. Sequenom offers further clarification on the scope of patent-eligible subject matter.

44. Federal Circuit rules Myriad's 'primers' and methods are not patent-eligible subject matter.

45. Novel outcome at the ITC: patent claims invalidated under Alice in the 100-day pilot program.

46. Patents 101: patentable subject matter and separation of powers.

47. Echoes from the past: how the Federal Circuit continues to struggle with patentable subject matter post-Bilski.

49. The rules and standards of patentable subject matter.

50. The Supreme Court reaffirmed that the door to patent eligibility should remain broad and open but failed to offer clear guidance on how business method patents are to be judged in the future.

Catalog

Books, media, physical & digital resources